More than a third (33%) of essential generic medicines were withdrawn from the Portuguese market in the last ten years, ...

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® ...

Walmart shares just saw their worst weekly performance since May 2022 — tumbling almost 9%. The stock price fell more than 6% ...

Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally.

Discover Bausch Health's Q4 2024 earnings highlights, showcasing revenue growth, strategic pillars, and key segment performance.

The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 ...

The current health news highlights Abridge raising $250 million to boost AI medical documentation, layoffs involving ...

Teva Pharmaceuticals' CEO advocates for quicker FDA generic drug approvals, which he argues would save the U.S. healthcare system money. Concurrently, the Trump administration has revised the number ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

Life sciences trade association BioNJ has announced the election of its 2025 Officers and Board Members in concert with BioNJ ...

Shares of Axsome Therapeutics ( AXSM -0.40%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, gaining as much as 25% earlier in the day. The move up comes as the S&P ...